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Definite multiple system atrophy
in a German family
Multiple system atrophy (MSA) is a pre-
sumed sporadic neurodegenerative disorder
of unknown aetiology, clinically charac-
terised by poorly levodopa responsive par-
kinsonism and/or cerebellar dysfunction in
combination with autonomic failure.1 We
previously identified a family with a typical
MSA phenotype in two successive genera-
tions.2 One affected patient of that pedigree,
now deceased at age 82, and postmortem
examination of the brain revealed findings
typical of definite MSA.3 Severe atrophy of
the putamen (fig 1A) and depigmentation of
the substantia nigra and pontine and cere-
bellar atrophy were found upon macroscopic
inspection. Formalin-fixed, paraffin
embedded sections stained with haematox-
ylin/eosin showed profound neuronal loss
Figure 1 Gross and microscopic findings in familial multiple system atrophy. (A) Atrophy and
brownish discoloration of the putamen. Immunostaining for a-synuclein revealed numerous glial
cytoplasmic inclusions in putamen (B) and cerebellar white matter (C). The insert in (B) shows a
higher magnification of the inclusions. Scale bar, 50 mm in (B) and (C) and 12.5 mm in the insert in
(B).
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and gliosis in the striatum, globus pallidus,
substantia nigra pars compacta, pontine
nuclei and inferior olivary nuclei, marked
Purkinje-cell loss and demyelination of
cerebellar white matter. Immunohisto-
chemistry for a-synuclein (SNCA) revealed
widespread glial cytoplasmic inclusions
(GCIs) most numerous in the basal ganglia
(fig 1B), cerebellar white matter (fig 1C),
brainstem and spinal cord, and moderate
numbers of GCIs in the frontal white matter
and corpus callosum. Only mild Alzheimer-
related pathology with single tau-positive
neurofibrillar tangles and neuropil threads in
the entorhinal and transentorhinal cortex
was detectable, and immunohistochemistry
with an antibody against TDP-43 was
negative (not shown). Sequencing of the
entire coding region of the a-synuclein gene
revealed no mutation; further, quantitative
PCR of exon 3 and exon 4 showed no
increased SNCA dosage (data not shown).
Genetic testing had excluded spinocere-
bellar ataxia (SCA) types 1–3, 6, 7 and 17 in
the presented family.2 In line with pre-
viously published data, we also found no
mutation in the SCNA gene or a gene dosage
effect in the deceased patient.4 5 Our find-
ings suggest that the present diagnostic
criteria for MSA, which explicitly exclude
patients with ‘‘a family history of a similar
disorder,’’ might have led to an under-
estimation of familial MSA cases.1 It may
be prudent to take into account the possi-
bility of a hereditary component in MSA
and to search for more families along the
quest to resolve the aetiology of MSA.
Similar to Parkinson disease, genetic analysis
of larger families might provide clues to the
aetiology of this devastating disease.
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